The added value of integrative medicine
Managing editor Professor Gordon McVie provides us with the highlights of ecancer for April 2016.
Journal
The steady progress of targeted therapies, promising advances for lung cancer
Video
EBMT 2016 Highlights: Expert discussion
Is PD-L1 really a predictive biomarker?
Simposio ecancer/SAC en cáncer de próstata
Don't forget to check out ecancer's 1st International Symposium on Radiation in the city of Santiago de Chile.
The added value of integrative medicine
New classification for identifying HR myeloma based on cytogenetic abnormalities
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma in a resource constrained setting
Genomic testing: Awareness and effective communication between healthcare professionals and patients
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Management of prostate cancer in Africa: Looking to the future